Blog
In-depth analysis of retatrutide research, emerging findings, and evidence-based commentary
Emerging ResearchSafety & Emerging Research
Retatrutide and Alcohol Use Disorder
Early preclinical findings, the GLP-1 reward-pathway hypothesis, and what the evidence does — and does not — show about GLP-1 receptor agonists and alcohol consumption.
8 min read
Retatrutide and Cancer
The GLP-1 class thyroid C-cell precaution, MASH-related hepatocellular carcinoma risk reduction research, and what early observational data on GLP-1 drugs and cancer does — and does not — show.
9 min read
All articles on TryTrutide are educational and do not constitute medical advice. Retatrutide is investigational and not FDA-approved for any indication. Editorial policy · Evidence methodology